Polymer-based thermoresponsive hydrogels for controlled drug delivery / Elisa Lacroce, Filippo Rossi
ABSTRACT Introduction Controlled drug delivery through hydrogels is generally limited by the poor barrier that polymeric network can create to diffusion mechanism. Stimuli responsive polymers can help in this way guaranteeing that delivery can be sustained and finely controlled using an external stimulus. Area covered This review provides an overview of recent studies about the use of temperature as an external stimulus able to work as an efficient new route of drug’s administration. Thermoresponsive hydrogels are discussed and compared in terms of physical properties and mechanism of drug release considering their classification in intrinsical (formed by thermosensitive polymers) and non-intrinsical (polymers with thermosensitive moieties) hydrogels. Expert opinion Thermoresponsive hydrogels can be developed by using different polymers added or not with micro/nanoparticles of organic or inorganic origin. In both cases, the final system represents an innovative way for the local and sustained drug delivery in a specific site of the body. In particular, it is possible to obtain an on-demand release of drug by applying a local increase of temperature to the system.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
---|---|
Enthalten in: |
Expert opinion on drug delivery - 19(2022), 10, Seite 1203-1215 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Lacroce, Elisa [VerfasserIn] |
---|
Links: |
FID Access [lizenzpflichtig] |
---|
Themen: |
Drug delivery |
---|
Umfang: |
1 Online-Ressource (13 p) |
---|
doi: |
10.1080/17425247.2022.2078806 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
KFL011127805 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | KFL011127805 | ||
003 | DE-627 | ||
005 | 20231109210021.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230609s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/17425247.2022.2078806 |2 doi | |
035 | |a (DE-627)KFL011127805 | ||
035 | |a (KFL)prod_LgpH_10.1080/17425247.2022.2078806 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
084 | |a PHARM |q DE-84 |2 fid | ||
100 | 1 | |a Lacroce, Elisa |e verfasserin |4 aut | |
245 | 1 | 0 | |a Polymer-based thermoresponsive hydrogels for controlled drug delivery |c Elisa Lacroce, Filippo Rossi |
264 | 1 | |c 2022 | |
300 | |a 1 Online-Ressource (13 p) | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a ABSTRACT Introduction Controlled drug delivery through hydrogels is generally limited by the poor barrier that polymeric network can create to diffusion mechanism. Stimuli responsive polymers can help in this way guaranteeing that delivery can be sustained and finely controlled using an external stimulus. Area covered This review provides an overview of recent studies about the use of temperature as an external stimulus able to work as an efficient new route of drug’s administration. Thermoresponsive hydrogels are discussed and compared in terms of physical properties and mechanism of drug release considering their classification in intrinsical (formed by thermosensitive polymers) and non-intrinsical (polymers with thermosensitive moieties) hydrogels. Expert opinion Thermoresponsive hydrogels can be developed by using different polymers added or not with micro/nanoparticles of organic or inorganic origin. In both cases, the final system represents an innovative way for the local and sustained drug delivery in a specific site of the body. In particular, it is possible to obtain an on-demand release of drug by applying a local increase of temperature to the system | ||
653 | |a Drug delivery | ||
653 | |a thermoresponsive | ||
653 | |a hydrogels | ||
653 | |a macromolecules | ||
653 | |a polymers | ||
700 | 1 | |a Rossi, Filippo |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Expert opinion on drug delivery |d Abingdon : Taylor & Francis Group, 2004 |g 19(2022), 10, Seite 1203-1215 |h Online-Ressource |w (DE-627)KFL000006114 |w (DE-600)2232223-1 |w (DE-576)302970223 |x 1744-7593 |7 nnns |
773 | 1 | 8 | |g volume:19 |g year:2022 |g number:10 |g pages:1203-1215 |
856 | 4 | 0 | |u http://pharmazie.proxy.fid-lizenzen.de/fid/tandf-ejournals-pharmazie/doi.org/10.1080/17425247.2022.2078806 |m X:KFL |x Resolving-System |y FID Access |z lizenzpflichtig |
912 | |a ZDB-1-TFE | ||
912 | |a GBV_KFL | ||
912 | |a FID-PHARM | ||
935 | |i IMPORT_0628_prod_LgpH_05 | ||
951 | |a AR | ||
952 | |d 19 |j 2022 |e 10 |h 1203-1215 |